HepaTx Corporation
The Development Of A Regenerative Cell Technology As An Alternative To Liver Transplants
https://wefunder.com/hepatx
Total raised on Wefunder: 55000
Total investors: 6
Quick facts
- Raised $2.4M from Venture funds, including $500k from Greysky Venture Partners
- Raised >$2M from Y Combinator Demo Day ($150k from YC, standard investment)
- Collaboration and license deal with the Mayo Clinic to execute a first-in-human trial
- $700k in grant funding received to date
- Backed by prestigious venture funds and accelerators, including Y Combinator and StartX
- Founded on breakthrough technology from Stanford University